Examining the fundamental biology of a novel population of directly reprogrammed human neural precursor cells

被引:21
作者
Ahlfors, Jan-Eric [1 ]
Azimi, Ashkan [2 ,3 ]
El-Ayoubi, Rouwayda [1 ]
Velumian, Alexander [4 ,6 ]
Vonderwalde, Ilan [5 ]
Boscher, Cecile [1 ]
Mihai, Oana [1 ]
Mani, Sarathi [1 ]
Samoilova, Marina [6 ]
Khazaei, Mohamad [6 ]
Fehlings, Michael G. [2 ,4 ,6 ]
Morshead, Cindi M. [2 ,3 ,5 ,7 ]
机构
[1] New World Labs, Laval, PQ H7V 5B7, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dept Surg, Div Anat, Toronto, ON M5S 1A8, Canada
[4] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON M5T 1P5, Canada
[5] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada
[6] Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON M5T 2S8, Canada
[7] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S3E1, Canada
关键词
drNPC; Direct reprogramming; Neural precursor cells; Neural stem cells; In vivo neurogenesis; In vivo remyelination; PLURIPOTENT STEM-CELLS; SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; PARKINSONS-DISEASE; PROGENITOR CELLS; TRANSPLANTATION; GENERATION; CONVERSION; NEURONS; MODELS;
D O I
10.1186/s13287-019-1255-4
中图分类号
Q813 [细胞工程];
学科分类号
摘要
BackgroundCell reprogramming is a promising avenue for cell-based therapies as it allows for the generation of multipotent, unipotent, or mature somatic cells without going through a pluripotent state. While the use of autologous cells is considered ideal, key challenges for their clinical translation include the ability to reproducibly generate sufficient quantities of cells within a therapeutically relevant time window.MethodsWe performed transfection of three distinct human somatic starting populations of cells with a non-integrating synthetic plasmid expressing Musashi 1 (MSI1), Neurogenin 2 (NGN2), and Methyl-CpG-Binding Domain 2 (MBD2). The resulting directly reprogrammed neural precursor cells (drNPCs) were examined in vitro using RT-qPCR, karyotype analysis, immunohistochemistry, and FACS at early and late time post-transfection. Electrophysiology (patch clamp) was performed on drNPC-derived neurons to determine their capacity to generate action potentials. In vivo characterization was performed following transplantation of drNPCs into two animal models (Shiverer and SCID/Beige mice), and the numbers, location, and differentiation profile of the transplanted cells were examined using immunohistochemistry.ResultsHuman somatic cells can be directly reprogrammed within twoweeks to neural precursor cells (drNPCs) by transient exposure to Msi1, Ngn2, and MBD2 using non-viral constructs. The drNPCs generate all three neural cell types (astrocytes, oligodendrocytes, and neurons) and can be passaged in vitro to generate large numbers of cells within fourweeks. drNPCs can respond to in vivo differentiation and migration cues as demonstrated by their migration to the olfactory bulb and contribution to neurogenesis in vivo. Differentiation profiles of transplanted cells onto the corpus callosum of myelin-deficient mice reveal the production of oligodendrocytes and astrocytes.ConclusionsHuman drNPCs can be efficiently and rapidly produced from donor somatic cells and possess all the important characteristics of native neural multipotent cells including differentiation into neurons, astrocytes, and oligodendrocytes, and in vivo neurogenesis and myelination.
引用
收藏
页数:17
相关论文
共 60 条
[1]  
Ahlfors J. - E., 2009, United States Patent Application No., Patent No. [61/ 256,967, 61256967]
[2]   Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient [J].
Amariglio, Ninette ;
Hirshberg, Abraham ;
Scheithauer, Bernd W. ;
Cohen, Yoram ;
Loewenthal, Ron ;
Trakhtenbrot, Luba ;
Paz, Nurit ;
Koren-Michowitz, Maya ;
Waldman, Dalia ;
Leider-Trejo, Leonor ;
Toren, Amos ;
Constantini, Shlomi ;
Rechavi, Gideon .
PLOS MEDICINE, 2009, 6 (02) :221-231
[3]   Transplanted CNS stem cells form functional synapses in vivo [J].
Auerbach, JM ;
Eiden, MV ;
McKay, RDG .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (05) :1696-1704
[4]   Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage [J].
Bar-Nur, Ori ;
Verheul, Cassandra ;
Sommer, Andreia G. ;
Brumbaugh, Justin ;
Schwarz, Benjamin A. ;
Lipchina, Inna ;
Huebner, Aaron J. ;
Mostoslavsky, Gustavo ;
Hochedlinger, Konrad .
NATURE BIOTECHNOLOGY, 2015, 33 (07) :761-768
[5]   Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease [J].
Beevers, Joel E. ;
Caffrey, Tara M. ;
Wade-Martins, Richard .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 :1503-1508
[6]   Modelling schizophrenia using human induced pluripotent stem cells [J].
Brennand, Kristen J. ;
Simone, Anthony ;
Jou, Jessica ;
Gelboin-Burkhart, Chelsea ;
Tran, Ngoc ;
Sangar, Sarah ;
Li, Yan ;
Mu, Yangling ;
Chen, Gong ;
Yu, Diana ;
McCarthy, Shane ;
Sebat, Jonathan ;
Gage, Fred H. .
NATURE, 2011, 473 (7346) :221-+
[7]   Plasmid-Based Generation of Induced Neural Stem Cells from Adult Human Fibroblasts [J].
Capetian, Philipp ;
Azmitia, Luis ;
Pauly, Martje G. ;
Krajka, Victor ;
Stengel, Felix ;
Bernhardi, Eva-Maria ;
Klett, Mariana ;
Meier, Britta ;
Seibler, Philip ;
Stanslowsky, Nancy ;
Moser, Andreas ;
Knopp, Andreas ;
Gillessen-Kaesbach, Gabriele ;
Nikkhah, Guido ;
Wegner, Florian ;
Doebroessy, Mate ;
Klein, Christine .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2016, 10
[8]   Patient-Specific Induced Pluripotent Stem Cells for SOD1-Associated Amyotrophic Lateral Sclerosis Pathogenesis Studies [J].
Chestkov, I. V. ;
Vasilieva, E. A. ;
Illarioshkin, S. N. ;
Lagarkova, M. A. ;
Kiselev, S. L. .
ACTA NATURAE, 2014, 6 (01) :54-60
[9]   Inducing pluripotency [J].
Clarke, Laura ;
van der Kooy, Derek .
NATURE MEDICINE, 2009, 15 (09) :1001-1002
[10]   Don't Look: Growing Clonal Versus Nonclonal Neural Stem Cell Colonies [J].
Coles-Takabe, Brenda L. K. ;
Brain, Ian ;
Purpura, Kelly A. ;
Karpowicz, Phillip ;
Zandstra, Peter W. ;
Morshead, Cindi M. ;
Van der Kooy, Derek .
STEM CELLS, 2008, 26 (11) :2938-2944